158 related articles for article (PubMed ID: 38554195)
21. Sequencing robot-assisted extended pelvic lymph node dissection prior to radical prostatectomy: a step-by-step guide to exposure and efficiency.
Williams SB; Bozkurt Y; Achim M; Achim G; Davis JW
BJU Int; 2016 Jan; 117(1):192-8. PubMed ID: 26190197
[TBL] [Abstract][Full Text] [Related]
22. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
[TBL] [Abstract][Full Text] [Related]
23. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
[TBL] [Abstract][Full Text] [Related]
24. Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (
Huits TH; Luiting HB; van der Poel HG; Nandurkar R; Donswijk M; Schaake E; Vogel W; Roobol MJ; Wit E; Stricker P; Emmett L; van Leeuwen PJ
BJU Int; 2020 Jun; 125(6):876-883. PubMed ID: 32181951
[TBL] [Abstract][Full Text] [Related]
25. Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy.
Liss MA; Palazzi K; Stroup SP; Jabaji R; Raheem OA; Kane CJ
World J Urol; 2013 Jun; 31(3):481-8. PubMed ID: 23512231
[TBL] [Abstract][Full Text] [Related]
26. Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissection.
Tafuri A; Amigoni N; Rizzetto R; Sebben M; Shakir A; Gozzo A; Odorizzi K; De Michele M; Gallina S; Bianchi A; Ornaghi P; Brunelli M; De Marco V; Verratti V; Migliorini F; Cerruto MA; Artibani W; Antonelli A; Porcaro AB
Int Urol Nephrol; 2020 Nov; 52(11):2097-2105. PubMed ID: 32607958
[TBL] [Abstract][Full Text] [Related]
27. Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy.
Oishi T; Hatakeyama S; Tabata R; Fujimori D; Fukuda M; Shinozaki T; Ishii N; Iwamura H; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Sato S; Ohyama C
Sci Rep; 2023 Mar; 13(1):3436. PubMed ID: 36859718
[TBL] [Abstract][Full Text] [Related]
28. Robot-Assisted Extended Pelvic Lymph Nodes Dissection for Prostate Cancer: Personal Surgical Technique and Outcomes.
Porpiglia F; De Luca S; Bertolo R; Passera R; Mele F; Manfredi M; Amparore D; Morra I; Fiori C
Int Braz J Urol; 2015; 41(6):1209-12019. PubMed ID: 26742982
[TBL] [Abstract][Full Text] [Related]
29. Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature.
Ploussard G; Briganti A; de la Taille A; Haese A; Heidenreich A; Menon M; Sulser T; Tewari AK; Eastham JA
Eur Urol; 2014 Jan; 65(1):7-16. PubMed ID: 23582879
[TBL] [Abstract][Full Text] [Related]
30.
Yılmaz B; Şahin S; Ergül N; Çolakoğlu Y; Baytekin HF; Sökmen D; Tuğcu V; Taşçı Aİ; Çermik TF
Ann Nucl Med; 2022 Jul; 36(7):597-609. PubMed ID: 35426599
[TBL] [Abstract][Full Text] [Related]
31. Open approach, extended pelvic lymph node dissection, and seminal vesicle invasion are independent predictors of hospital readmission after prostate cancer surgery: a large retrospective study.
Sebben M; Tafuri A; Pirozzi M; Processali T; Rizzetto R; Amigoni N; Shakir A; De Michele M; Panunzio A; Cerrato C; Tiso L; Novella G; Brunelli M; Migliorini F; De Marco V; Siracusano S; Artibani W; Porcaro AB
Minerva Urol Nefrol; 2020 Feb; 72(1):72-81. PubMed ID: 31833722
[TBL] [Abstract][Full Text] [Related]
32. American Society of Anesthesiologists (ASA) physical status system predicts the risk of postoperative Clavien-Dindo complications greater than one at 90 days after robot-assisted radical prostatectomy: final results of a tertiary referral center.
Porcaro AB; Rizzetto R; Bianchi A; Gallina S; Serafin E; Panunzio A; Tafuri A; Cerrato C; Migliorini F; Zecchini Antoniolli S; Novella G; De Marco V; Brunelli M; Siracusano S; Cerruto MA; Polati E; Antonelli A
J Robot Surg; 2023 Jun; 17(3):987-993. PubMed ID: 36436107
[TBL] [Abstract][Full Text] [Related]
33. Bilateral Peritoneal Flaps Reduce Incidence and Complications of Lymphoceles after Robotic Radical Prostatectomy with Pelvic Lymph Node Dissection-Results of the Prospective Randomized Multicenter Trial ProLy.
Gloger S; Ubrig B; Boy A; Leyh-Bannurah SR; Siemer S; Arndt M; Stolzenburg JU; Franz T; Oelke M; Witt JH
J Urol; 2022 Aug; 208(2):333-340. PubMed ID: 35422136
[TBL] [Abstract][Full Text] [Related]
34. Extended robot-assisted laparoscopic prostatectomy and extended pelvic lymph node dissection as a monotherapy in patients with very high-risk prostate cancer Patients.
Miura N; Sugihara N; Funaki K; Kakuda T; Koyama K; Watanabe R; Sawada Y; Noda T; Nishimura K; Fukumoto T; Miyauchi Y; Kikugawa T; Saika T
Cancer Med; 2021 Nov; 10(22):7968-7976. PubMed ID: 34562303
[TBL] [Abstract][Full Text] [Related]
35. Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database.
McGinley KF; Sun X; Howard LE; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ
Int J Urol; 2016 Mar; 23(3):241-6. PubMed ID: 26667212
[TBL] [Abstract][Full Text] [Related]
36. Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer.
Gondoputro W; Scheltema MJ; Blazevski A; Doan P; Thompson JE; Amin A; Geboers B; Agrawal S; Siriwardana A; Van Leeuwen PJ; van Oosterom MN; Van Leeuwen FWB; Emmett L; Stricker PD
J Nucl Med; 2022 Nov; 63(11):1659-1664. PubMed ID: 35241483
[TBL] [Abstract][Full Text] [Related]
37. Robot-assisted Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer.
Montorsi F; Gandaglia G; Fossati N; Suardi N; Pultrone C; De Groote R; Dovey Z; Umari P; Gallina A; Briganti A; Mottrie A
Eur Urol; 2017 Sep; 72(3):432-438. PubMed ID: 27600589
[TBL] [Abstract][Full Text] [Related]
38. Robot-assisted extended pelvic lymph node dissection in prostate cancer. When and how?
Sierra PS; Lestingi JFP; Albuquerque EV; Pontes J; de Carvalho PA; Cavalcante A; Guglielmetti GB; Nahas WC; Coelho RF
Arch Esp Urol; 2019 Apr; 72(3):257-265. PubMed ID: 30945652
[TBL] [Abstract][Full Text] [Related]
39. Prospective Randomized Trial Comparing Titanium Clips to Bipolar Coagulation in Sealing Lymphatic Vessels During Pelvic Lymph Node Dissection at the Time of Robot-assisted Radical Prostatectomy.
Grande P; Di Pierro GB; Mordasini L; Ferrari M; Würnschimmel C; Danuser H; Mattei A
Eur Urol; 2017 Feb; 71(2):155-158. PubMed ID: 27544575
[TBL] [Abstract][Full Text] [Related]
40. Robot-assisted Radical Prostatectomy Performed with Different Robotic Platforms: First Comparative Evidence Between Da Vinci and HUGO Robot-assisted Surgery Robots.
Bravi CA; Balestrazzi E; De Loof M; Rebuffo S; Piramide F; Mottaran A; Paciotti M; Sorce G; Nocera L; Sarchi L; Peraire M; Colla'-Ruvolo C; Frego N; Piro A; Ticonosco M; De Backer P; Farinha R; Van Den Bossche H; De Naeyer G; D'Hondt F; De Groote R; Mottrie A
Eur Urol Focus; 2024 Jan; 10(1):107-114. PubMed ID: 37634969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
